This report provides information on the therapeutic development for Coronary Vasospasm, complete with latest updates, and special features on late-stage and discontinued projects.

1. Coronary Vasospasm - Pipeline Review, Q3 2011
Coronary Vasospasm - Pipeline Review, Q3 2011
Summary
Global Markets Direct’s, 'Coronary Vasospasm - Pipeline Review, Q3 2011', provides an
overview of the Coronary Vasospasm therapeutic pipeline. This report provides information
on the therapeutic development for Coronary Vasospasm, complete with latest updates,
and special features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Coronary Vasospasm. 'Coronary Vasospasm -
Pipeline Review, Q3 2011' is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-
specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability
and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Coronary Vasospasm.
- A review of the Coronary Vasospasm products under development by companies and
universities/research institutes based on information derived from company and industry-
specific sources.
- Coverage of products based on various stages of development ranging from discovery till
registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Coronary Vasospasm market on the basis of therapeutic class, route of
administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description,
mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Browse All Pharmaceuticals Market Research Reports
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Coronary Vasospasm.
- Identify emerging players with potentially strong product portfolio and design effective
counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising
pipeline.
- Devise corrective measures for pipeline projects by understanding Coronary Vasospasm
pipeline depth and focus of Coronary Vasospasm therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand business potential and
scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding
the factors that drove them from pipeline.

2. Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Coronary Vasospasm Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Coronary Vasospasm 6
Coronary Vasospasm Therapeutics under Development by Companies 8
Coronary Vasospasm Therapeutics under Investigation by Universities/Institutes 9
Late Stage Products 10
Comparative Analysis 10
Discovery and Pre-Clinical Stage Products 11
Comparative Analysis 11
Coronary Vasospasm Therapeutics - Products under Development by Companies 12
Coronary Vasospasm Therapeutics - Products under Investigation by Universities/Institutes
13
Coronary Vasospasm - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Drug Profiles 19
NimoGel - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
NimoGel - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Sildenafil - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Coronary Vasospasm Therapeutics – Drug Profile Updates 24
Coronary Vasospasm - Featured News 25
Oct 04, 2010: Edge Provides Update On NimoGel 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 27
Contact Us 27
Disclaimer 27

3. About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsandreports.com
http://www.reportsandreports.com
Visit our Market Research Blog